We previously reported anatomical plasticity in the adult motor cortex after a unilateral sensorimotor cortex (SMC) lesion and treatment with monoclonal antibody (mAb) IN-1, which permits neurite outgrowth from the intact, opposite cortex into deafferented subcortical targets. This study was designed to investigate whether treatment with the mAb IN-1 after SMC lesion in the adult leads to functional reorganization of the intact, opposite motor cortex. Adult rats underwent unilateral SMC aspiration lesion and treatment with either mAb IN-1 or control antibody, or no treatment. After a 6 week survival period, the intact, opposite forelimb motor cortex was explored using intracortical microstimulation to evoke forelimb movements. A dramatic increase in ipsilateral movements of the lesion-impaired forelimb was found in animals treated with mAb IN-1 compared with control animals. These results resembled our previous findings of cortical reorganization in the spared hemisphere after neonatal cortical lesion and without any additional treatment. These results show that, after adult cortical lesion, treatment with mAb IN-1 induces a functional reorganization of the intact, opposite motor cortex.
Introduction
Contrary to conditions during development, the mature CNS has less capacity to form new neuronal connections after injury. Such new connections (i.e., anatomical plasticity) may be the underlying substrate for the substantial functional recovery often seen after lesion in the young (for review, see Kolb and Whishaw, 1989) . One explanation for the decreased amount of anatomical plasticity after adult CNS injury is the presence of myelinassociated inhibitory factors that block neurite outgrowth (Schwab, 2002) . One such factor is Nogo-A, a protein product of the Nogo gene (Chen et al., 2000; GrandPré et al., 2000; Prinjha et al., 2000) , which is expressed at the cell surface of oligodendrocytes . Application of anti-Nogo-A antibodies in the normal adult results in transient axonal outgrowth in cerebellar Purkinje cells (Buffo et al., 2000) and corticospinal neurons, concomitantly with the upregulation of several growthrelated proteins and growth factors (Bareyre et al., 2002) . Nogo-A and one of its receptors, Nogo-66 receptor (NgR), are juxtaposed along myelinated axons in the adult (Wang et al., 2002) , and NgR blockade results in sustained axonal outgrowth in the corticospinal tract (CST) after spinal cord lesions (GrandPré et al., 2002) .
Our previous work has shown that treatment with the monoclonal antibody (mAb) IN-1 raised against NI-250 (later renamed Nogo-A) after cortical lesions in adult rats results in the formation of new corticoefferent connections from the intact, opposite cortex to the deafferented striatum , red nucleus (Wenk et al., 1999; Papadopoulos et al., 2002) , and basilar pontine nuclei (Wenk et al., 1999) . Those results were strikingly similar to anatomical results found after neonatal cortical lesions with no treatment, in which the intact, opposite motor cortex sends projections to the deafferented striatum (Kolb et al., 1992 (Kolb et al., , 1994 , red nucleus (Leong and Lund, 1973; Nah and Leong, 1976; Naus et al., 1985 Naus et al., , 1986 Murakami and Higashi, 1988) , basilar pontine nuclei (Leong and Lund, 1973; Castro and Mihailoff, 1983; Kartje-Tillotson et al., 1986) , and spinal cord gray matter (Hicks and D'Amato, 1970; Leong and Lund, 1973; Castro, 1975; Leong, 1976; Whishaw and Kolb, 1988; Barth and Stanfield, 1990; Kuang and Kalil, 1990; Rouiller et al., 1991) .
In support of the functional role of the anatomical plasticity reported after neonatal lesions, electrophysiological studies showed that neonatal cortical lesions also result in a reorganization of the intact, opposite cortex (Kartje-Tillotson et al., 1985 , 1987 . In this work, low-current microstimulation in the unablated opposite motor cortex elicited movement of the lesionimpaired forelimb, thereby indicating new functional connections that could compensate for lost motor input.
The purpose of the present study was to investigate the possibility of functional reorganization of the motor cortex after adult cortical lesion when treated with mAb IN-1. Accordingly, reorganization of the intact, opposite motor cortex was observed in animals with sensorimotor cortex (SMC) lesion and mAb IN-1 treatment that corresponded to an increase in movements of the lesion-impaired forelimb, similar to previous findings after neocortical lesions with no treatment.
Materials and Methods
Animals. All of the animal procedures were approved by the Joint Institutional Animal Care and Use Committee of Loyola University and Hines Veterans Affairs Hospital. Eighteen male Long-Evans blackhooded rats at 8 -10 weeks of age were divided into the following four experimental groups: (1) SMC lesion plus mAb IN-1 (n ϭ 6), (2) SMC lesion plus control Ab (n ϭ 4), (3) SMC lesion only (n ϭ 4), and (4) normal (n ϭ 4).
Sensorimotor aspiration lesion. Animals were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) supplemented with ketamine (40 mg/kg, i.m.) as needed. Anesthetized animals were then secured in a stereotaxic frame, and the scalp was incised along the midline. With the bregma as a landmark, the skull was opened to expose the left sensorimotor cortex, and the forelimb and hindlimb motor cortex was aspirated with gentle suction using the following coordinates: 4.0 mm rostral, 2.0 mm caudal, 1.0 mm medial, and 4.0 mm lateral to bregma .
Antibody application. Immediately after cortical aspiration lesion and while animals were still anesthetized, mouse hybridoma cells (1 ϫ 10 5 cells in 1 l) secreting either mAb IN-1 or control antibody (anti-HRP) were delivered by Hamilton syringe posterior to the lesion site into the hippocampus (4.0 mm caudal, 5.0 mm lateral, and 5.0 mm ventral to bregma). Previous work has shown that application of the hybridoma secreting cells near the lateral ventricle results in the secretion of antibody into the CSF and diffusion throughout the brain Z'Graggen et al., 1998; Kartje et al., 1999; Wenk et al., 1999; Papadopoulos et al., 2002) . All of the animals, including control animals, received daily injections of cyclosporin A (10 mg/kg, i.p.) 1 d before and 7 d after surgery to suppress host rejection of the mouse hybridoma cells. Animals were returned to standard housing conditions.
Intracortical microstimulation mapping of forelimb motor cortex. Six weeks after SMC lesion, animals underwent intracortical microstimulation (ICMS) for cortical mapping as described previously Z'Graggen et al., 2000) . Animals were reanesthetized with ketamine (100 mg/kg, i.m.) and xylazine (5 mg/kg, i.p.) with supplemental doses of ketamine (20 mg/kg, i.m.; given as needed). They were secured in a stereotaxic frame while resting on a heating pad set to 37°C. The forelimbs and shoulders were shaved to better facilitate observation of movements. Before opening the skull, the cisterna magna was opened and drained to reduce swelling of the cortex. Using a dental drill and rongeurs, the skull overlaying the right, nonlesioned SMC was removed, the dura was opened, and the brain was kept moist with warm mineral oil. Using bregma as a cranial landmark, the motor forelimb area ( Fig. 1 ) was explored in 0.25-0.5 mm steps with a stimulating electrode (a sharpened, glass-insulated tungsten wire with a noninsulated tip length of 100 m). The stimulation current (2-80 A) was applied as a 300 msec train of 0.25 msec pulses at 350 Hz with an electrode depth of 1.7 mm below the cortical pial surface. Stimulus currents were monitored on an oscilloscope by measuring the voltage drop across a 10 k⍀ resistor. One investigator applied stimulation current, while another investigator blinded to the experimental group observed movements.
For each animal, a map of the SMC was generated, demonstrating the topographical organization of forelimb movements at threshold stimulating currents. The area of the forelimb cortex was mapped to its rostralcaudal and medial-lateral borders as defined by previous mapping experiments . All of the cortical points were screened for movements at 80 A, and the current threshold was determined as the lowest current necessary to reliably produce a visible movement. When a forelimb movement was observed, the current threshold was recorded for the contralateral limb first and the ipsilateral, lesionimpaired limb second (if present), along with the type of movement elicited. All of the forelimb movements were grouped into two categories: distal (digit or wrist) and proximal (elbow or shoulder). Individual forelimb motor maps from each animal were then combined to make a representative map for each experimental group.
Results
In animals from all of the groups, forelimb movements were elicited from cortical areas consistent with the caudal forelimb motor cortex described previously . Stimulation of the cortex surrounding the forelimb region elicited various types of movements: tongue, jaw, and nose (rostrally); hip, ankle, toe, and tail (caudally); and vibrissas (medially). The lateral border was characterized by a lack of observed movements, even at higher thresholds, indicating stimulation of the sensory cortex. The area of forelimb maps for all of the groups was in a consistent location: between 4.0 mm anterior and 0.5 mm posterior to bregma and between 1.5 and 4.0 mm lateral to bregma. Therefore, there was no shift in forelimb boundaries between animal groups.
In normal animals, ICMS of the forelimb motor cortex at stimulation threshold resulted primarily in contralateral movements (46 responsive stimulation sites), with few ipsilateral movements (6 responsive stimulation sites) (Fig. 2) . Ipsilateral movements were not evoked without a contralateral movement at the same cortical point. Similar findings occurred in animals with lesion or lesion plus control antibody (Fig. 2) in which ICMS at stimulation threshold evoked mostly contralateral movements (lesion only, 55 responsive stimulation sites; lesion plus control antibody, 91 responsive stimulation sites) with only a few ipsilateral movements (lesion only, 13 responsive stimulation sites; lesion plus control antibody, 14 responsive stimulation sites). In marked contrast, animals sustaining SMC lesion plus mAb IN-1 treatment showed a dramatic increase in ipsilateral forelimb movements (81 responsive stimulation sites) evoked from the intact, opposite cortex in addition to the presence of evoked contralateral movements (132 responsive stimulation sites) (Fig. 2) . Additional statistical analysis (Fig. 3) showed a significant increase in the percentage of stimulation points that evoked ipsilateral movements in the SMC lesion plus mAb IN-1 treatment group in comparison with that of normals, the SMC lesion-only group, and SMC lesion plus control antibody group ( p Ͻ 0.001; one-way ANOVA with Bonferroni post test). There was no statistical difference between the percentage of ipsilateral forelimb movements in other treatment groups.
Contralateral forelimb movements were evoked at low thresholds (13-16 A) in all of the groups, with no statistical difference in the average current threshold for evoked contralateral movements (data not shown). Ipsilateral forelimb movements were evoked at slightly higher current thresholds (27-31 A) in all of the experimental groups ( p Ͼ 0.01; unpaired t test), and there was no statistical difference when comparing the average ipsilateral current threshold among experimental groups (data not shown). Additionally, there was no apparent difference in the relative responsiveness of the nonlesioned SMC among experimental groups (data not shown).
We next examined the distribution of proximal and distal evoked forelimb movements. In the contralateral forelimb, nearly an equal proportion of proximal and distal movements were evoked in all of the experimental groups (data not shown). In the ipsilateral forelimb, however, proximal movements were significantly greater than distal movements in all of the experimental groups ( p Ͻ 0.01; one-way ANOVA) (Fig. 4) . There was no statistical difference, however, when comparing the categories of movements ( p Ͼ 0.05; one-way ANOVA). Thus, although treatment with mAb IN-1 did increase the frequency of evoked ipsilateral movements, it did not change the types of movements.
Discussion
This study demonstrates that intracerebral application of mAb IN-1 results in cortical reorganization of the intact, opposite motor cortex after SMC lesion in adult rats. ICMS mapping of the motor cortex in the hemisphere opposite to the lesion revealed a dramatic increase in ipsilateral movements in the lesionimpaired forelimb compared with control groups.
Recent clinical reports indicate that, after adult brain damage, the motor cortex is capable of reorganizing. In recovered stroke patients, several studies have reported an increase in motor cortical activity in the nonstroke hemisphere during movement of the ipsilateral, stroke-affected hand, suggesting that the nondamaged hemisphere plays an important role in recovery (for review, see Cramer, 1999) . Recent studies have shown that bilateral activation of the motor cortex occurs with unilateral hand movements in patients with nondisabling multiple sclerosis and that such adaptive responses might be important for maintaining motor function after cortical damage (Lee et al., 2000; Reddy et al., 2000; Rocca et al., 2002) . Studies in animals have also shown that the adult motor cortex is capable of some functional reorganization, and such cortical changes might contribute to the limited spontaneous recovery observed after injury (for review, see Nudo et al., 2001 ). In the rodent, the sensorimotor cortex reorganizes in response to motor nerve injury , forelimb amputation , and partial spinal cord injury . Abo et al. (2001) observed that increased functional magnetic resonance imaging activity in the nonstroke hemisphere contributes to the spontaneous recovery of hindlimb function after ischemic stroke in rats. Additional behavioral studies are needed to evaluate whether such new connections contribute to the recovery of limb use.
Our results confirm previous reports that a small, but functional, pathway exists for ipsilateral forelimb movements in the normal adult rat (Kartje-Tillotson et al., 1985 , 1987 . In animals treated with mAb IN-1 after cortical injury, an increase was found in the ipsilateral forelimb movements without any changes in the current thresholds or types of movements. These results indicate that mAb IN-1 treatment might result in the expansion or strengthening of a preexisting neuroanatomical pathway that contributes to ipsilateral movements, such as the ipsilateral dorsal or ventral CSTs . The motor cortex might also mediate control of the ipsilateral forelimb through the remodeling of other descending motor tracts including the crossed CST or the rubrospinal tract. We reported previously that mAb IN-1 treatment leads to increased corticoefferent projections from the intact cortex to the deafferented red nucleus after cortical aspiration lesions (Wenk et al., 1999) and stroke (Papadopoulos et al., 2002) , thereby restoring cortical input to the rubrospinal system in the damaged hemisphere and possibly contributing to the observed recovery from motor impairments after stroke. Wiessner et al. (2002 Wiessner et al. ( , 2003 have also reported that treatment with a different antibody against Nogo-A after ischemic stroke induces significant axonal outgrowth from the crossed CST into the deafferented spinal cord correlated with improved behavioral outcome. We are currently investigating which pathways might be mediating ipsilateral forelimb movements in animals treated with mAb IN-1 after SMC lesions.
Another important result from this study is that the lesion alone does not increase ipsilateral forelimb movements or alter the characteristics of the forelimb map. The lack of lesioninduced changes in the opposite cortex is not surprising, because others have reported previously that aspiration lesion alone does not result in anatomical plasticity in the adult (Napieralski et al., 1996; Uryu et al., 2001) , nor is there any slow-wave neural activity that might be associated with axonal outgrowth (Carmichael and Chesselet, 2002) . Furthermore, there is no change in the expression of molecules associated with neuronal growth after aspiration lesions (Szele et al., 1995) . However, treatment with mAb IN-1 after CST lesions has been shown to induce the upregulation of growth factors (brain-derived neurotrophic factor and vascular endothelial growth factor) and growth-associated proteins (actin, myosin, and GAP-43) and results in the enhanced expression of axonal guidance molecules (semaphorins and slits) and neurotrophic factors (insulin-like growth factor and bone morphogenic protein) (Bareyre et al., 2002) . These changes in gene expression were found concomitantly with significant axonal outgrowth from the intact CST into deafferented spinal cord areas. Treatment with mAb IN-1 after SMC lesions might also result in such changes in gene expression and contribute to the observed functional reorganization in the motor cortex.
We and others have shown that treatment with either mAb IN-1 or other anti Nogo-A antibodies after adult cortical lesions Wenk et al., 1999; Papadopoulos et al., 2002; Wiessner et al., 2002 Wiessner et al., , 2003 or CST lesions (Bregman et al., 1995; Thallmair et al., 1998; Z'Graggen et al., 1998; Merkler et al., 2001; Raineteau et al., 2001 ) results in neuroanatomical plasticity and/or neuronal regeneration correlated with behavioral recovery. In support of these neuroanatomical and behavioral results, this study provides evidence that mAb IN-1 (i.e., Nogo-A blockade) after adult cortical injury results in a physiological reorganization of the motor cortex that is functionally meaningful. This observed functional reorganization could be important for recovery of motor control after cortical damage resulting from stroke, traumatic brain injury, multiple sclerosis, or spinal cord injury.
